Enterprise software shares have plunged more than 20% this month, the worst drop since October 2008. Investors are reassessing whether legacy licensing and subscription models can coexist with rapid advances in generative AI. Palantir’s shares fell over 15% during this downturn despite no change in its underlying customer count, highlighting market concerns over an industry-wide revaluation rather than company-specific issues.

Ahead of its February earnings release, Palantir is forecast to deliver year-over-year revenue growth exceeding 100%, driven by commercial adoption of its AI Platform. Analysts project that new contract awards will push total contract value past $1.2 billion. However, consensus estimates caution that margins may compress if investment in R&D and sales and marketing accelerates to support expansion into new regions.

An examination of the last seven quarterly results shows that the stock rose following five announcements and declined after two, with average share moves of ±10% in the two weeks after earnings. Strong commercial revenue momentum—up 121% year-over-year in North America last quarter—has underpinned rallies, while any signs of slower enterprise bookings triggered pullbacks.

Palantir enters this reporting period with over $6 billion in cash, no debt on the balance sheet, and improving operating margins, which expanded by 400 basis points sequentially last quarter. Despite this financial strength, the stock trades at more than 100 times forward revenue, requiring sustained double-digit top-line growth to justify its valuation. Any deceleration in enterprise AI spending could quickly test investor conviction.